• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FDA Watch: How Could the End of Chevron Impact the FDA and LDTs?

FDA Watch: How Could the End of Chevron Impact the FDA and LDTs?

by Ron Shinkman | Jul 24, 2024 | Essential, FDA-lca, Lab Industry Advisor, LDTs-lir

A lawsuit by a group of herring fishermen upended 40 years of legal precedent regarding how federal agencies interpret statutes

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule

Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule

by Scott Wallask | Jul 4, 2024 | Elite, FDA-lca, Lab Industry Advisor

Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain

New FDA LDTs Guidance Offers Useful Summary, But Questions Remain

by Rachel Muenz | Jun 27, 2024 | News

Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details

LDTs Around the World

LDTs Around the World

by Michael Schubert, PhD | Jun 4, 2024 | Enforcement-lca, Essential, Lab Industry Advisor, LDTs-lir, Legislation-lca, Top of the News-lir

Curious about how laboratory-developed tests are regulated in other countries? We compare in-house test guidance across six regions

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
3 Thoughts on the FDA’s Final LDTs Rule

3 Thoughts on the FDA’s Final LDTs Rule

by Rachel Muenz | May 14, 2024 | News

Regulatory expert Julie Ballard shares her first thoughts on the final rule for lab-developed tests and immediate steps for labs

« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com